Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2114234 | 1.00 | GRIN1 (0.33) | GRIN1GRIN2BLTA4HCHRM2CHRM3 | |
| SCHEMBL18159722 | 1.00 | GRIN1 (0.33) | GRIN1GRIN2BLTA4HCHRM2CHRM3 | |
| SCHEMBL6044051 | 0.95 | HTR4 (0.34) | GRIN1GRIN2BLTA4HCHRM2CHRM3 | |
| SCHEMBL2116532 | 0.89 | ACHE (0.39) | ACHEMAOB | |
| SCHEMBL6043379 | 0.89 | SLC18A3 (0.37) | GRIN1GRIN2BLTA4HKMT2A | |
| SCHEMBL2116387 | 0.89 | HRH3 (0.37) | CHRM3ACHEMAOBHRH1MEN1 | |
| SCHEMBL15685468 | 0.89 | SLC18A3 (0.37) | GRIN1GRIN2BLTA4HKMT2A | |
| SCHEMBL15685469 | 0.89 | SLC18A3 (0.37) | GRIN1GRIN2BLTA4HKMT2A | |
| Hydrochloric Acid SCHEMBL25364283 | 0.87 | SLC18A3 (0.36) | GRIN1GRIN2BLTA4HLMNA | |
| SCHEMBL14968346 | 0.84 | GBA1 (0.38) | MEN1KMT2ASIGMAR1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710439-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2020-09-23 | — | — | EP | disclosed |
| EP-3458445-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2019-03-27 | — | — | EP | disclosed |
| WO-2019036384-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2019-02-21 | — | — | WO | disclosed |
| WO-2017201161-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2017-11-23 | — | — | WO | disclosed |